John Deacon

Title: John Deacon: Innovator in Immuno-Stimulatory Delivery Systems

Introduction

John Deacon is an accomplished inventor based in Tolland, Connecticut. He is known for his innovative work in the field of immunology, particularly in the development of novel delivery systems for immuno-stimulatory compounds. His contributions have the potential to significantly impact therapeutic strategies in various medical applications.

Latest Patents

John Deacon holds a patent for his invention titled "pHLIP®-mediated intracellular delivery of immuno-stimulatory compounds." This invention features a composition that includes an immuno-stimulatory compound and a pHLIP® peptide. The immuno-stimulatory compound comprises a cyclic purine dinucleotide, which binds to a stimulator of interferon genes (STING) such as a cGAMP cyclic compound inside a cell. This innovative approach aims to enhance the efficacy of immunotherapy.

Career Highlights

Throughout his career, John Deacon has worked with prestigious institutions, including the University of Rhode Island and Yale University. His experience in these academic environments has allowed him to collaborate with leading researchers and contribute to significant advancements in his field.

Collaborations

John has collaborated with notable colleagues, including Yana K Reshetnyak and Oleg A Andreev. These partnerships have fostered a rich exchange of ideas and have been instrumental in the development of his patented technologies.

Conclusion

John Deacon's innovative work in immuno-stimulatory delivery systems exemplifies the impact of research and invention in the medical field. His contributions continue to pave the way for advancements in immunotherapy and related applications.